| Labatec Pharma SA - Letrozol Labatec 2.5 mg, comprimés pelliculés | | 65164 | | 01 | | Letrozol Labatec 2.5 mg | | comprimés pelliculés | | L02BG04 | | Letrozole | | 24.06.2014 | | |
| | Composition | | letrozolum 2.5 mg, cellulosum microcristallinum silicificatum, carboxymethylamylum natricum A, magnesii stearas, pellicule: poly(alcohol vinylicus), macrogolum 3350, talcum, E 171, E 172 (flavum), E 110 0.016 mg, pro compresso obducto corresp. natrium 0.212 mg. | | Packungsbestandteile | | Coated tablets | | | | | Active Agent | Dose |
|---|
| Letrozol | 2.5 mg |
| | BAG: Active Agent | Dose |
|---|
| Letrozol | 2.5 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| | | | | | | | | | | | | | 0.016 mg | color. | | | | color. | | | | color. | | Macrogol | 3350 | | | | | | | | | pellicule | | | | | | Talcum | | |
| |
| |
|
